Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corifollitropin alfa vs Daily FSH in Poor Ovarian Responders
NCT04695483Phase 4Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Feb 2022
- Primary completion
- Jan 2024
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of corifollitropin alfa in infertility (2 arms), sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Premature progesterone elevation at Day 12. Started Feb 2022; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT04695483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04695483.